Holen Sie sich die Stockscreener-App
30.60
0.85%
-0.23
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TGTX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$30.83
Offen:
$30.72
24-Stunden-Volumen:
530.87K
Relative Volume:
0.29
Marktkapitalisierung:
$4.86B
Einnahmen:
$264.79M
Nettoeinkommen (Verlust:
$-14.36M
KGV:
-278.18
EPS:
-0.11
Netto-Cashflow:
$-28.11M
1W Leistung:
-0.20%
1M Leistung:
-5.18%
6M Leistung:
-23.27%
1J Leistung:
-6.91%
1-Tages-Spanne:
$30.52
$31.21
1-Wochen-Bereich:
$30.44
$32.26
52-Wochen-Spanne:
$25.28
$46.48
Tg Therapeutics Inc Stock (TGTX) Company Profile
Firmenname
Tg Therapeutics Inc
Sektor
Branche
Telefon
(212) 554-4484
Adresse
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Vergleichen Sie TGTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
30.61 | 4.89B | 264.79M | -14.36M | -28.11M | -0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
440.48 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
698.65 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
417.28 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
893.79 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
194.49 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-06 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-07-10 | Fortgesetzt | Goldman | Neutral |
| 2024-10-29 | Eingeleitet | TD Cowen | Buy |
| 2023-08-02 | Hochstufung | Goldman | Sell → Neutral |
| 2023-06-26 | Fortgesetzt | Jefferies | Buy |
| 2022-05-20 | Eingeleitet | BofA Securities | Underperform |
| 2022-02-23 | Bestätigt | B. Riley Securities | Buy |
| 2021-11-15 | Herabstufung | Goldman | Neutral → Sell |
| 2021-04-20 | Eingeleitet | Goldman | Neutral |
| 2021-04-19 | Bestätigt | H.C. Wainwright | Buy |
| 2020-09-01 | Eingeleitet | JP Morgan | Overweight |
| 2020-08-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-05 | Eingeleitet | Evercore ISI | Outperform |
| 2020-01-17 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-02-06 | Fortgesetzt | Jefferies | Buy |
| 2018-09-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | Fortgesetzt | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-04-25 | Eingeleitet | Jefferies | Buy |
| 2017-03-06 | Bestätigt | FBR & Co. | Outperform |
| 2016-10-06 | Fortgesetzt | Brean Capital | Buy |
| 2016-05-27 | Eingeleitet | SunTrust | Buy |
| 2015-12-01 | Eingeleitet | FBR Capital | Outperform |
| 2015-09-09 | Eingeleitet | Raymond James | Strong Buy |
| 2015-08-12 | Fortgesetzt | H.C. Wainwright | Buy |
| 2015-06-19 | Bestätigt | Brean Capital | Buy |
| 2014-12-11 | Bestätigt | ROTH Capital | Buy |
| 2014-12-10 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten
TG Therapeutics, Inc. $TGTX Shares Acquired by Jump Financial LLC - MarketBeat
1832 Asset Management L.P. Has $5.18 Million Stock Holdings in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Lacklustre Performance Is Driving TG Therapeutics, Inc.'s (NASDAQ:TGTX) Low P/S - 富途牛牛
New York State Common Retirement Fund Boosts Stake in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
TG Therapeutics, Inc. $TGTX Shares Bought by Russell Investments Group Ltd. - MarketBeat
Is TG Therapeutics Inc. (NKB2) stock nearing a technical breakout2025 Trading Recap & Verified Swing Trading Watchlists - Newser
Is TG Therapeutics Still Attractively Priced After Recent Multiple Sclerosis Expansion Progress? - Sahm
Why TG Therapeutics Inc. (NKB2) stock stays resilient2025 Analyst Calls & Fast Entry High Yield Stock Tips - Newser
TG Therapeutics (TGTX) Earnings Date and Reports 2026 - MarketBeat
TG Therapeutics (TGTX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
With TG Therapeutics Stock Sliding, Have You Assessed The Risk? - Trefis
Legal & General Group Plc Has $13.18 Million Stock Holdings in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. $TGTX Shares Acquired by Prudential Financial Inc. - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Price-Driven Insight from (TGTX) for Rule-Based Strategy - news.stocktradersdaily.com
Is TG Therapeutics Inc NKB2 a good long term investmentGrowth Stock Opportunities & Affordable Investment Portfolio - earlytimes.in
11,012 Shares in TG Therapeutics, Inc. $TGTX Purchased by Inceptionr LLC - MarketBeat
Can Clinical Progress Updates Boost TG Therapeutics' Value in 2025? - Yahoo Finance
11,676 Shares in TG Therapeutics, Inc. $TGTX Bought by Rockefeller Capital Management L.P. - MarketBeat
TG Therapeutics (TGTX): Assessing Valuation and Growth Narrative Following Recent Market Attention - Sahm
TG Therapeutics CEO Michael S. Weiss to Speak at 8th Annual Evercore Healthcare Conference - Quiver Quantitative
TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference - The Manila Times
Why TG Therapeutics Inc. stock remains on watchlists2025 Volatility Report & Stepwise Trade Execution Plans - BỘ NỘI VỤ
TG Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit - Sahm
TG Therapeutics (TGTX) Is Up After Raising 2025 Revenue Guidance Has the Growth Story Strengthened? - Sahm
Can TG Therapeutics Inc. stock surprise with earnings upsideEarnings Trend Report & Fast Entry High Yield Stock Tips - moha.gov.vn
TG Therapeutics TGTX Q3 2025 Earnings Transcript - Nasdaq
Summit Global Investments Purchases Shares of 12,216 TG Therapeutics, Inc. $TGTX - MarketBeat
Rhenman & Partners Asset Management AB Sells 62,500 Shares of TG Therapeutics, Inc. $TGTX - MarketBeat
Director At TG Therapeutics Sells $162K Of Stock - Benzinga
TG Therapeutics Director Sells Shares to Cover Tax Obligations - TradingView
Dir Echelard Sells 5,000 ($162.9K) Of TG Therapeutics Inc [TGTX] - TradingView
TGTX Form 4: Director Yann Echelard stock sale and holdings - Stock Titan
Ensign Peak Advisors Inc Sells 20,900 Shares of TG Therapeutics, Inc. $TGTX - MarketBeat
What macro factors could drive TG Therapeutics Inc. (NKB2) stock higherJuly 2025 Sector Moves & Breakout Confirmation Alerts - newser.com
What insider purchases suggest about TG Therapeutics Inc. (NKB2) stockQuarterly Portfolio Report & Smart Investment Allocation Insights - newser.com
Will TG Therapeutics Inc. stock outperform tech sector in 2025Trade Signal Summary & Daily Oversold Stock Bounce Ideas - newser.com
TG Therapeutics Makes 2025 Deloitte Technology Fast 500 List of America's Fastest-Growing Companies - MarketScreener
Why TG Therapeutics Inc. (NKB2) stock trades below fair valueJuly 2025 Institutional & Momentum Based Trading Ideas - newser.com
TG THERAPEUTICS INC (1TGTX.MI) Stock Price, News, Quote & History - Yahoo! Finance Canada
TG Therapeutics Makes 2025 Deloitte Technology Fast 500™ List of America’s Fastest-Growing Companies - The Globe and Mail
TG THERAPEUTICS INC (1TGTX.MI) stock price, news, quote and history - Yahoo Finance UK
TG Therapeutics, Inc. $TGTX Shares Sold by Intech Investment Management LLC - MarketBeat
(TGTX) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Is TG Therapeutics Inc. stock oversold or undervaluedGap Up & Low Risk High Win Rate Stock Picks - newser.com
Will TG Therapeutics Inc. stock benefit from commodity pricesJuly 2025 Outlook & Consistent Profit Alerts - newser.com
Can TG Therapeutics Inc. stock resist market sell offs2025 Performance Recap & Advanced Swing Trade Entry Plans - newser.com
Finanzdaten der Tg Therapeutics Inc-Aktie (TGTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.22%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):